Modulation of KCNQ potassium channel activity for treatment of psychiatric disorders and the symptoms thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 28, 2015
Grant Date -
Dec 9, 2010
app pub date -
Jun 3, 2010
filing date -
Jun 3, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein are compositions and methods for treating a psychiatric disorder or symptoms thereof in a patient. The compositions comprise a compound that modulates KCNQ (Kv7) potassium channel activity and the methods include administering an effective amount of the compound that modulates KCNQ (Kv7) potassium channel activity.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully